Expression of ice, bcl-2, c-myc and p53 in different bone marrow cell populations from patients with diffuse large B-cell lymphoma

References

• Harris N L, Jaffe E S, Stein H, Banks P M, Chan J KC, Cleary M L, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 1994; 84: 1361–1365
   PubMed Web of Science ®Google Scholar
• Hiddemann W, Longo D L, Coiffier B, Fisher R I, Cabanillas F, Cavalli F, et al. Lymphoma classification – the gap between biology and clinical management is closing. Blood 1996; 88: 4085–4089
   PubMed Web of Science ®Google Scholar
• Rossi D, Gaidano G. Molecular Heterogeneity of diffuse large B-cell lymphoma: implications for disease management and prognosis. Hematology 2002; 7: 239–252
   PubMedGoogle Scholar
• Farrugia M M, Duan L, Reis M D, Ngan B Y, Berinstein N L. Alterations of the p53 tumor supressor gene in diffuse large cell lymphomas with translocations of the c-myc and bcl-2 proto-oncogenes. Blood 1994; 83: 191–198
   PubMed Web of Science ®Google Scholar
• Alizadeh A A, Eisen M B, Davis E R, Ma C, Lossos I S, Rosenwald A, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503–511
   PubMed Web of Science ®Google Scholar
• Shipp M A, Ross K N, Tamayo P, Weng A P, Kutok J, Aguiar R C, et al. Diffuse large B-cell lymphoma outcome prediction by gene expression profiling and supervised machine learning. Nature Med 2002; 8: 68–74
   PubMed Web of Science ®Google Scholar
• Rosenwald A, Wright G, Chan C W, Connors M J, Campo E, Fisher R I, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 1937–1947
   PubMed Web of Science ®Google Scholar
• Huerta-Zepeda A, Talavera A, Avilés A, Neri N, Mayani H. In vitro hematopoiesis in patients with malignant lymphoma during active disease and at complete clinical remission after chemotherapy. Leuk Lymphoma 2000; 39: 613–624
   PubMed Web of Science ®Google Scholar
• Martínez-Jaramillo G, Avilés A, Neri N, Huerta J, Madrigal-Velázquez M, Flores-Guzmán P, et al. In vitro proliferation and expansion of hematopoietic progenitors from patients with diffuse large B-cell lymphoma before and after chemotherapy. Leuk Lymphoma 2004; 45: 1247–1254
   PubMed Web of Science ®Google Scholar
• Harris N L, Jaffe E S, Stein H, Banks P M, Chan J, Cleary M L, et al. A revised European American classification of lymphoid neoplasms proposed by the International study group. A summary version. Am J Clin Pathol 1995; 103: 539–540
   PubMed Web of Science ®Google Scholar
• Chávez-González M A, Rosas-Cabral A, Vela-Ojeda J, González J C, Mayani H. Severe functional alterations in vitro in CD34+ cell subpopulations from patients with chronic myeloid leukemia. Leuk Res 2004; 28: 639–647
   PubMed Web of Science ®Google Scholar
• Koduru R KP, Raju K, Vadmal V, Menezes G, Shah S, Susin M, et al. Correlation between mutation in p53, p53 expression, cytogenetics, histologic type, and survivial in patients with B-cell Non-Hodgkin's lymphoma. Blood 1997; 10: 4078–4091
   Google Scholar
• Ichikawa A, Hotta T, Takagi N, Tsuchita K, Kinoshita T, Nagai H, et al. Mutations of p53 gene and their relation to disease progression in B-cell lymphoma. Blood 1992; 79: 2701–2707
   PubMed Web of Science ®Google Scholar
• McKeithan T W. Molecular biology of non-Hodgkin's lymphoma. Sem Oncol 1990; 17: 30–42
   PubMed Web of Science ®Google Scholar
• Albalwi M, Hammond D W, Goepel J R, Hough R E, Goyns M H. Semi-quantitative fluorescence In situ hybridization analysis indicates that the myc protein is consistently stabilized both before and after transformation of low-grade follicular center to high-grade diffuse large cell lymphoma. Lab Invest 1999; 70: 707–715
   Google Scholar
• Perscarmona E, De Santis V, Pistilli A, Pacchiarotti A, Martelli M, Guglielmi C, et al. Pathogenic and clinical implications of bcl-6 and bcl-2 gene configuration in nodal diffuse large B-cell lymphomas. J Pathol 1997; 183: 281–286
   PubMed Web of Science ®Google Scholar
• Monni O, Joensuuh H, Franssila K, Klefstrom J, Aitalo K, Knuutila S. BCL2 overexpression associated with chromosomal amplification in diffuse large cell lymphoma. Blood 1997; 90: 1168–1174
   PubMed Web of Science ®Google Scholar
• Szilvassy S J. The biology of hematopoietic stem cells. Arch Med Res 2003; 34: 446–460
   PubMed Web of Science ®Google Scholar
• Chen G, Gharib T G, Huan C C, Taylor J M, Misek D E, Kardia S L, et al. Discrodant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics 2002; 1: 304–313
   PubMed Web of Science ®Google Scholar
• Nordengren J, Casslen B, Gustavsson B, Einardottir M, Willen R. Discordant expression of mRNA and protein for urokinase and tissue plasminogen actiators (u-PA,t-PA) in endometrial carcinoma. Int J Cancer 1998; 17: 195–201
   Google Scholar
• Liang Y, Van Zant G. Genetic control of stem cell properties and stem cells in aging. Curr Opin Hematol 2003; 10: 195–202
   PubMed Web of Science ®Google Scholar
• Macintyre E A, Belanger C, Debert C, Canioni D, Turhan A G, Azaguri M, et al. Detection of clonal CD34+ 19+ progenitors in bone marrow of bcl-2-IgH-positive follicular lymphoma patients. Blood 1995; 86: 4691–4698
   PubMed Web of Science ®Google Scholar
• Voso M T, Hohaus S, Moos M, Haas R. Lack of t(14;18) polymerase chain reaction-positive cells in highly purified CD34+ cells and their CD19 subsets in patients with follicular lymphoma. Blood 1997; 89: 3763–3768
   PubMed Web of Science ®Google Scholar
• Katsenberger T, Lohr A, Schwarz S, Dreyling M, Schoof J, Nickenig C, et al. Genetic analysis of de novo CD5+ diffuse large B-cell lymphomas suggests an origin from a somatically mutated CD5+ progenitor B cell. Blood 2003; 101: 699–702
   PubMed Web of Science ®Google Scholar
• Yarkoni S, Lishner M, Tangi I, Nagler A, Lorberboum-Galski H. B-cell non-Hodgkin's lymphoma: evidence for the t(14;18) translocation in all hematopoietic cell lineages. J Natl Cancer Inst 1996; 88: 973–979
   PubMed Web of Science ®Google Scholar
• Strauchen J A. Primary bone marrow B-cell lymphoma. Report of four cases. Mount Sinai J Med 2003; 70: 133–138
   PubMed Web of Science ®Google Scholar
• Alvares L C, Matutes E, Scully A M, Swansbury J, Min T, Gruszka A M, et al. Isolated bone marrow involvement in diffuse large B cell lymphoma: a report of three cases with review of morphological, immunophenotypic and cytogenetic findings. Leuk Lymphoma 2004; 45: 469–475
   PubMed Web of Science ®Google Scholar
• Gniadecki R, Lukowsky A, Rossen K, Madsen H O, Thomsen K, Wulf H C. Bone marrow precursor of extranodal T-cell lymphoma. Blood 2003; 102: 3797–3799
   PubMed Web of Science ®Google Scholar
• Amé-Thomas P, Deschaseaux F, Mauny F, Bulabois C -E, Lamy T, Hervé P, et al. In vitro functional defects of bone marrow-derived CD34+ progenitors from newly diagnosed mature B-cell malignancies with bone marrow tumor involvement. Exp Hematol 2005; 33: 318–328
   PubMed Web of Science ®Google Scholar